Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 285 (RN7SKP285) is annotated as a pseudogene in the human genome. Pseudogenes are typically non-functional genomic DNA sequences similar to known genes, but generally lack protein-coding ability or functional RNA expression. Unlike the canonical RN7SK gene, which encodes a highly abundant and functionally significant small nuclear non-coding RNA involved in transcriptional regulation[1][2], RN7SKP285 shows no evidence of functional RNA or protein product, nor is there any indication from major gene, biomedical, or pharmacological databases that it plays a role as a molecular drug target or in any disease process[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 285 (RN7SKP285).